Generic Drugs
Generics Drug Market
In this section you will find information products, including market research, on the Generics Drug Market, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
|
Generics Global Industry Guide |
October 2010 | £1495 |
|
Generic and Biogeneric Drugs
for 15 Major Therapeutic Categories U.S./E.U./Japan/ROW Market Trends and Directions 2008-2013 |
January 2010 | £1255 |
|
Ophthalmic Pharmaceutical Drugs A Global Market Perspective |
November 2009 | £1905 |
|
Generics in Japan |
November 2009 | £1825 |
|
Booming US Generic Drug Market |
August 2009 | £765 |
|
Generic Drug Market in Canada |
August 2009 | £765 |
|
Report on Antihypertensive Drug Market |
May 2009 | £350 |
|
GenericHandbook - Third Edition (2009) A Guide to the Generic Drug Industry in the US |
April 2009 | £475 |
|
Global. Generics |
April 2009 | £800 |
|
How to Forecast Generic Pharmaceutical Prices A practical methodology to calculate future generic product prices |
March 2009 | £2500 |
|
Mirtazapine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Midazolam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Mometasone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Micafungin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Modafinil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Memantine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Meloxicam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Montelukast: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Meropenem: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Metformin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Metronidazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Nateglinide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Olanzapine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Octreotide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Olmesartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Olopatadine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Omega-3-acid ethyl esters: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Nicorandil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Nebivolol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Moxifloxacin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Mycophenolic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Naratriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Meloxicam (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Moxidectin (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Linezolid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Lacidipine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ivermectin & Praziquantel (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Lamivudine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Lamotrigine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Lansoprazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Doxorubicin Pipeline Developer |
Ongoing | £3795 |
|
Dorzolamide Pipeline Developer |
Ongoing | £2925 |
|
Docetaxel Pipeline Developer |
Ongoing | £3795 |
|
Desvenlafaxine Pipeline Developer |
Ongoing | £2925 |
|
Donepezil Pipeline Developer |
Ongoing | £3360 |
|
Doramectin (Vet) Pipeline Developer |
Ongoing | £3360 |
|
Doripenem Pipeline Developer |
Ongoing | £3360 |
|
Lapatinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Latanoprost: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Levothyroxine sodium: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Levosalbutamol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Omeprazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Loratadine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Losartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Levofloxacin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Levocetirizine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Leflunomide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Lercanidipine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Letrozole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Levetiracetam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Medetomidine (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Desloratadine Pipeline Developer |
Ongoing | £2925 |
|
Rituximab: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ritonavir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rivastigmine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rizatriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rocuronium Bromide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Risperidone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Risedronic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Reboxetine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rasagiline: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Repaglinide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Riluzole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rimonabant: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ropinirole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ropivacaine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sildenafil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sibutramine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Simvastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sirolimus: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sitagliptin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sevelamer: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sertraline: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rosiglitazone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rosuvastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Roxithromycin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Salmeterol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ramipril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ramelteon: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pemetrexed: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pegfilgrastim: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Penciclovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pergolide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Perindopril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Paroxetine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Paricalcitol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Oxaliplatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Orlistat: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Paclitaxel: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Palonosetron: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pantoprazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pioglitazone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pitavastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Quinapril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Quetiapine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Rabeprazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ractopamine (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Raloxifene: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pyriproxyfen (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pregabalin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Posaconazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pramipexole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Prasugrel: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pravastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ondansetron: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Citalopram Pipeline Developer |
Ongoing | £2925 |
|
Topotecan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Topiramate: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tramadol & Paracetamol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Trandolapril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Trastuzumab: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tolterodine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tolfenamic acid (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tibolone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Thalidomide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tigecycline: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tiletamine (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tiotropium Bromide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Travoprost: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Valaciclovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Zidovudine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Voriconazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ziprasidone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Zolazepam (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Zoledronic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Vinorelbine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Venlafaxine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Valganciclovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Valsartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Vardenafil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Varenicline: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Teriparatide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Terbinafine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sildenafil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sibutramine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Simvastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sirolimus: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sitagliptin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sevelamer: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sertraline: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rosiglitazone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rosuvastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Roxithromycin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Salmeterol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Solifenacin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sorafenib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Telmisartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Teicoplanin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Temozolomide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Temsirolimus: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tenofovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tazobactam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tamsulosin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sumatriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sunitinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tacrolimus: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Tadalafil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Zolmitriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Abacavir Pipeline Developer |
Ongoing | £3360 |
|
Carvedilol Pipeline Developer |
Ongoing | £2485 |
|
Carprofen (Vet) Pipeline Developer |
Ongoing | £2485 |
|
Caspofungin Pipeline Developer |
Ongoing | £3360 |
|
Cefditoren Pipeline Developer |
Ongoing | £3360 |
|
Cefprozil Pipeline Developer |
Ongoing | £2485 |
|
Capecitabine Pipeline Developer |
Ongoing | £2925 |
|
Candesartan Pipeline Developer |
Ongoing | £3795 |
|
Budesonide Pipeline Developer |
Ongoing | £3360 |
|
Brinzolamide Pipeline Developer |
Ongoing | £2925 |
|
Buprenorphine Pipeline Developer |
Ongoing | £2925 |
|
Cabergoline Pipeline Developer |
Ongoing | £2050 |
|
Calcipotriol Pipeline Developer |
Ongoing | £2925 |
|
Ceftiofur (Vet) Pipeline Developer |
Ongoing | £3360 |
|
Cefuroxime Pipeline Developer |
Ongoing | £2485 |
|
Cladribine Pipeline Developer |
Ongoing | £2485 |
|
Solifenacin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Clarithromycin Pipeline Developer |
Ongoing | £2925 |
|
Clopidogrel Pipeline Developer |
Ongoing | £2925 |
|
Darbepoetin alfa Pipeline Developer |
Ongoing | £4320 |
|
Cisatracurium Pipeline Developer |
Ongoing | £2485 |
|
Ciprofloxacin Pipeline Developer |
Ongoing | £3360 |
|
Celecoxib Pipeline Developer |
Ongoing | £3795 |
|
Cetuximab Pipeline Developer |
Ongoing | £4320 |
|
Ciclosporin Pipeline Developer |
Ongoing | £3360 |
|
Ciclosporin (Vet) Pipeline Developer |
Ongoing | £3360 |
|
Brimonidine Pipeline Developer |
Ongoing | £2925 |
|
Bosentan Pipeline Developer |
Ongoing | £2925 |
|
Aliskiren Pipeline Developer |
Ongoing | £3360 |
|
Alfuzosin Pipeline Developer |
Ongoing | £2485 |
|
Almotriptan Pipeline Developer |
Ongoing | £3360 |
|
Amorolfine Pipeline Developer |
Ongoing | £2485 |
|
Amphotericin B Pipeline Developer |
Ongoing | £4320 |
|
Alendronic Acid & Colecalciferol Pipeline Developer |
Ongoing | £3360 |
|
Alendronic Acid Pipeline Developer |
Ongoing | £2925 |
|
Acitretin Pipeline Developer |
Ongoing | £2485 |
|
Adalimumab Pipeline Developer |
Ongoing | £4320 |
|
Adapalene Pipeline Developer |
Ongoing | £2925 |
|
Adefovir Pipeline Developer |
Ongoing | £3360 |
|
Anastrozole Pipeline Developer |
Ongoing | £2925 |
|
Aripiprazole Pipeline Developer |
Ongoing | £3360 |
|
Bicalutamide Pipeline Developer |
Ongoing | £2485 |
|
Bevacizumab Pipeline Developer |
Ongoing | £4320 |
|
Bimatoprost Pipeline Developer |
Ongoing | £2925 |
|
Bisoprolol Pipeline Developer |
Ongoing | £2485 |
|
Bortezomib Pipeline Developer |
Ongoing | £3360 |
|
Barnidipine Pipeline Developer |
Ongoing | £3360 |
|
Azithromycin Pipeline Developer |
Ongoing | £2925 |
|
Armodafinil Pipeline Developer |
Ongoing | £2925 |
|
Atorvastatin Pipeline Developer |
Ongoing | £3360 |
|
Atovaquone Pipeline Developer |
Ongoing | £2485 |
|
Azelastine Pipeline Developer |
Ongoing | £3360 |
|
Dasatinib Pipeline Developer |
Ongoing | £2925 |
|
Tamsulosin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Prasugrel Pipeline Developer |
Ongoing | £3360 |
|
Pramipexole Pipeline Developer |
Ongoing | £2925 |
|
Pravastatin Pipeline Developer |
Ongoing | £2925 |
|
Pregabalin Pipeline Developer |
Ongoing | £2925 |
|
Pyriproxyfen (Vet) Pipeline Developer |
Ongoing | £2485 |
|
Posaconazole Pipeline Developer |
Ongoing | £3795 |
|
Pitavastatin Pipeline Developer |
Ongoing | £3360 |
|
Penciclovir Pipeline Developer |
Ongoing | £3360 |
|
Pemetrexed Pipeline Developer |
Ongoing | £3360 |
|
Pergolide Pipeline Developer |
Ongoing | £2485 |
|
Perindopril Pipeline Developer |
Ongoing | £2925 |
|
Pioglitazone Pipeline Developer |
Ongoing | £3360 |
|
Quetiapine Pipeline Developer |
Ongoing | £2925 |
|
Quinapril Pipeline Developer |
Ongoing | £2485 |
|
Repaglinide Pipeline Developer |
Ongoing | £2925 |
|
Reboxetine Pipeline Developer |
Ongoing | £3360 |
|
Riluzole Pipeline Developer |
Ongoing | £2485 |
|
Rimonabant Pipeline Developer |
Ongoing | £3360 |
|
Risedronic Acid Pipeline Developer |
Ongoing | £2925 |
|
Rasagiline Pipeline Developer |
Ongoing | £2925 |
|
Ramipril Pipeline Developer |
Ongoing | £2485 |
|
Rabeprazole Pipeline Developer |
Ongoing | £3795 |
|
Ractopamine (Vet) Pipeline Developer |
Ongoing | £2050 |
|
Raloxifene Pipeline Developer |
Ongoing | £3795 |
|
Ramelteon Pipeline Developer |
Ongoing | £2925 |
|
Pegfilgrastim Pipeline Developer |
Ongoing | £6975 |
|
Paroxetine Pipeline Developer |
Ongoing | £2925 |
|
Mycophenolic Acid Pipeline Developer |
Ongoing | £2925 |
|
Moxifloxacin Pipeline Developer |
Ongoing | £3795 |
|
Naratriptan Pipeline Developer |
Ongoing | £3360 |
|
Nateglinide Pipeline Developer |
Ongoing | £2925 |
|
Nebivolol Pipeline Developer |
Ongoing | £2485 |
|
Moxidectin (Vet) Pipeline Developer |
Ongoing | £2925 |
|
Montelukast Pipeline Developer |
Ongoing | £2925 |
|
Midazolam Pipeline Developer |
Ongoing | £2485 |
|
Mirtazapine Pipeline Developer |
Ongoing | £2485 |
|
Modafinil Pipeline Developer |
Ongoing | £2925 |
|
Mometasone Pipeline Developer |
Ongoing | £2925 |
|
Nicorandil Pipeline Developer |
Ongoing | £2485 |
|
Octreotide Pipeline Developer |
Ongoing | £2925 |
|
Oxaliplatin Pipeline Developer |
Ongoing | £2925 |
|
Orlistat Pipeline Developer |
Ongoing | £2485 |
|
Paclitaxel Pipeline Developer |
Ongoing | £3795 |
|
Pantoprazole Pipeline Developer |
Ongoing | £2925 |
|
Paricalcitol Pipeline Developer |
Ongoing | £2485 |
|
Ondansetron Pipeline Developer |
Ongoing | £2485 |
|
Omeprazole Pipeline Developer |
Ongoing | £3360 |
|
Olanzapine Pipeline Developer |
Ongoing | £2925 |
|
Olmesartan Pipeline Developer |
Ongoing | £3795 |
|
Olopatadine Pipeline Developer |
Ongoing | £2925 |
|
Omega-3-acid ethyl esters Pipeline Developer |
Ongoing | £4625 |
|
Risperidone Pipeline Developer |
Ongoing | £2485 |
|
Ritonavir Pipeline Developer |
Ongoing | £3795 |
|
Trandolapril Pipeline Developer |
Ongoing | £2485 |
|
Topiramate Pipeline Developer |
Ongoing | £2925 |
|
Trastuzumab Pipeline Developer |
Ongoing | £4320 |
|
Travoprost Pipeline Developer |
Ongoing | £2925 |
|
Valaciclovir Pipeline Developer |
Ongoing | £3360 |
|
Tolterodine Pipeline Developer |
Ongoing | £2925 |
|
Tiotropium Bromide Pipeline Developer |
Ongoing | £3360 |
|
Teriparatide Pipeline Developer |
Ongoing | £3795 |
|
Terbinafine Pipeline Developer |
Ongoing | £2485 |
|
Thalidomide Pipeline Developer |
Ongoing | £3360 |
|
Tibolone Pipeline Developer |
Ongoing | £2050 |
|
Tigecycline Pipeline Developer |
Ongoing | £3360 |
|
Valganciclovir Pipeline Developer |
Ongoing | £3360 |
|
Valsartan Pipeline Developer |
Ongoing | £3795 |
|
Zoledronic Acid Pipeline Developer |
Ongoing | £3360 |
|
Zolazepam (Vet) Pipeline Developer |
Ongoing | £2050 |
|
Zolmitriptan Pipeline Developer |
Ongoing | £2925 |
|
U.S. Market for Anti-Adhesion Products 2009 |
March 2009 | £4770 |
|
European Medical Device Company Profiles |
March 2009 | £3820 |
|
Ziprasidone Pipeline Developer |
Ongoing | £3795 |
|
Zidovudine Pipeline Developer |
Ongoing | £3360 |
|
Vardenafil Pipeline Developer |
Ongoing | £3360 |
|
Varenicline Pipeline Developer |
Ongoing | £2925 |
|
Venlafaxine Pipeline Developer |
Ongoing | £2485 |
|
Voriconazole Pipeline Developer |
Ongoing | £3795 |
|
Tenofovir Pipeline Developer |
Ongoing | £3795 |
|
Temsirolimus Pipeline Developer |
Ongoing | £3795 |
|
Salmeterol Pipeline Developer |
Ongoing | £2925 |
|
Roxithromycin Pipeline Developer |
Ongoing | £2925 |
|
Sertraline Pipeline Developer |
Ongoing | £2925 |
|
Sevelamer Pipeline Developer |
Ongoing | £2925 |
|
Sildenafil Pipeline Developer |
Ongoing | £3360 |
|
Rosuvastatin Pipeline Developer |
Ongoing | £3360 |
|
Rosiglitazone Pipeline Developer |
Ongoing | £3795 |
|
Rivastigmine Pipeline Developer |
Ongoing | £2925 |
|
Rizatriptan Pipeline Developer |
Ongoing | £3360 |
|
Ropinirole Pipeline Developer |
Ongoing | £2925 |
|
Ropivacaine Pipeline Developer |
Ongoing | £2485 |
|
Simvastatin Pipeline Developer |
Ongoing | £2485 |
|
Sirolimus Pipeline Developer |
Ongoing | £4320 |
|
Tamsulosin Pipeline Developer |
Ongoing | £2925 |
|
Tadalafil Pipeline Developer |
Ongoing | £3360 |
|
Tazobactam Pipeline Developer |
Ongoing | £2485 |
|
Telmisartan Pipeline Developer |
Ongoing | £3795 |
|
Temozolomide Pipeline Developer |
Ongoing | £2925 |
|
Tacrolimus Pipeline Developer |
Ongoing | £3360 |
|
Sunitinib Pipeline Developer |
Ongoing | £3360 |
|
Sitagliptin Pipeline Developer |
Ongoing | £3795 |
|
Solifenacin Pipeline Developer |
Ongoing | £2925 |
|
Sorafenib Pipeline Developer |
Ongoing | £3795 |
|
Sumatriptan Pipeline Developer |
Ongoing | £2925 |
|
Micafungin Pipeline Developer |
Ongoing | £3360 |
|
Meropenem Pipeline Developer |
Ongoing | £3360 |
|
Zidovudine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Voriconazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ziprasidone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Zolazepam (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Zoledronic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Vinorelbine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Venlafaxine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Valganciclovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Valaciclovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Valsartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Vardenafil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Varenicline: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Zolmitriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Drospirenone Pipeline Developer |
Ongoing | £3795 |
|
Entecavir Pipeline Developer |
Ongoing | £3360 |
|
Entacapone Pipeline Developer |
Ongoing | £2485 |
|
Eplerenone Pipeline Developer |
Ongoing | £2485 |
|
Epoetin alfa Pipeline Developer |
Ongoing | £4320 |
|
Eprosartan Pipeline Developer |
Ongoing | £3795 |
|
Enrofloxacin (Vet) Pipeline Developer |
Ongoing | £3360 |
|
Eletriptan Pipeline Developer |
Ongoing | £3360 |
|
Duloxetine Pipeline Developer |
Ongoing | £3360 |
|
Dutasteride Pipeline Developer |
Ongoing | £2925 |
|
Edaravone Pipeline Developer |
Ongoing | £3360 |
|
Efavirenz Pipeline Developer |
Ongoing | £4120 |
|
Travoprost: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Trastuzumab: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Telmisartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Teicoplanin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Temozolomide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Temsirolimus: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tenofovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tazobactam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ropivacaine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Sumatriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Sunitinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tacrolimus: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tadalafil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Terbinafine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Teriparatide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Topiramate: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tolterodine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Topotecan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tramadol & Paracetamol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Trandolapril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tolfenamic acid (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tiotropium Bromide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Thalidomide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tibolone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tigecycline: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Tiletamine (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Eptifibatide Pipeline Developer |
Ongoing | £3360 |
|
Erlotinib Pipeline Developer |
Ongoing | £3360 |
|
Lacidipine Pipeline Developer |
Ongoing | £2485 |
|
Itraconazole Pipeline Developer |
Ongoing | £3360 |
|
Lamivudine Pipeline Developer |
Ongoing | £3360 |
|
Lamotrigine Pipeline Developer |
Ongoing | £2485 |
|
Lansoprazole Pipeline Developer |
Ongoing | £2925 |
|
Isotretinoin Pipeline Developer |
Ongoing | £2925 |
|
Iron Sucrose Pipeline Developer |
Ongoing | £3360 |
|
Imiquimod Pipeline Developer |
Ongoing | £3360 |
|
Imidacloprid (Vet) Pipeline Developer |
Ongoing | £2925 |
|
Indapamide Pipeline Developer |
Ongoing | £2925 |
|
Irbesartan Pipeline Developer |
Ongoing | £3795 |
|
Irinotecan Pipeline Developer |
Ongoing | £3360 |
|
Lapatinib Pipeline Developer |
Ongoing | £2925 |
|
Latanoprost Pipeline Developer |
Ongoing | £2485 |
|
Losartan Pipeline Developer |
Ongoing | £3795 |
|
Linezolid Pipeline Developer |
Ongoing | £3360 |
|
Meloxicam Pipeline Developer |
Ongoing | £2485 |
|
Meloxicam (Vet) Pipeline Developer |
Ongoing | £2485 |
|
Memantine Pipeline Developer |
Ongoing | £2050 |
|
Levofloxacin Pipeline Developer |
Ongoing | £3795 |
|
Levocetirizine Pipeline Developer |
Ongoing | £2925 |
|
Leflunomide Pipeline Developer |
Ongoing | £2485 |
|
Lercanidipine Pipeline Developer |
Ongoing | £2925 |
|
Letrozole Pipeline Developer |
Ongoing | £2925 |
|
Levetiracetam Pipeline Developer |
Ongoing | £2925 |
|
Imatinib Pipeline Developer |
Ongoing | £3795 |
|
Ibandronic Acid Pipeline Developer |
Ongoing | £2925 |
|
Finasteride Pipeline Developer |
Ongoing | £2485 |
|
Fexofenadine Pipeline Developer |
Ongoing | £2485 |
|
Fipronil (Vet) Pipeline Developer |
Ongoing | £2925 |
|
Florfenicol (Vet) Pipeline Developer |
Ongoing | £2485 |
|
Fluconazole Pipeline Developer |
Ongoing | £2050 |
|
Fesoterodine Pipeline Developer |
Ongoing | £3360 |
|
Famciclovir Pipeline Developer |
Ongoing | £2925 |
|
Ertapenem Pipeline Developer |
Ongoing | £3795 |
|
Everolimus Pipeline Developer |
Ongoing | £3795 |
|
Exemestane Pipeline Developer |
Ongoing | £2925 |
|
Ezetimibe Pipeline Developer |
Ongoing | £3795 |
|
Fludarabine Pipeline Developer |
Ongoing | £4625 |
|
Fluticasone Pipeline Developer |
Ongoing | £3360 |
|
Gemcitabine Pipeline Developer |
Ongoing | £2925 |
|
Gefitinib Pipeline Developer |
Ongoing | £3360 |
|
Glatiramer acetate Pipeline Developer |
Ongoing | £3360 |
|
Glimepiride Pipeline Developer |
Ongoing | £2485 |
|
Hepatitis B Vaccine Pipeline Developer |
Ongoing | £4320 |
|
Galantamine Pipeline Developer |
Ongoing | £3360 |
|
Gadopentetic acid Pipeline Developer |
Ongoing | £3360 |
|
Fluvastatin Pipeline Developer |
Ongoing | £3360 |
|
Fosinopril Pipeline Developer |
Ongoing | £2485 |
|
Frovatriptan Pipeline Developer |
Ongoing | £3360 |
|
Gabapentin Pipeline Developer |
Ongoing | £2485 |
|
Sorafenib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ropinirole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Galantamine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Gefitinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Gemcitabine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Glatiramer acetate: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Gadopentetic acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Gabapentin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Formoterol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fosinopril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Frovatriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Glimepiride: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Hepatitis B Vaccine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Imidacloprid (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Imiquimod: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Indapamide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Irbesartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Imatinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ibandronic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Hirudin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Hyaluronic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Hydroxychloroquine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fluvoxamine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fluvastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Erlotinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ertapenem: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Everolimus: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Exemestane: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Eptifibatide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Eprosartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Entecavir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Eplerenone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Epoetin alfa: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ezetimibe: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Famciclovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Florfenicol (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fluconazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fludarabine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fluticasone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fipronil (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Finasteride: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fesoterodine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Fexofenadine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Filgrastim: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Irinotecan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Iron Sucrose: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Midazolam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Mirtazapine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Modafinil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Mometasone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Micafungin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Metronidazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Memantine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Meropenem: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Metformin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Montelukast: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Moxidectin (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Nicorandil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Octreotide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Olanzapine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Olmesartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Nebivolol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Nateglinide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Moxifloxacin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Mycophenolic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Naratriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Meloxicam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Meloxicam (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lansoprazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lapatinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Latanoprost: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Leflunomide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lamotrigine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lamivudine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Isotretinoin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Itraconazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lacidipine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Lercanidipine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Letrozole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Linezolid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Loratadine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Losartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Medetomidine (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Levothyroxine sodium: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Levosalbutamol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Levetiracetam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Levocetirizine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Levofloxacin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Entacapone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Enrofloxacin (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bevacizumab: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bicalutamide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bimatoprost: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bisoprolol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Barnidipine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Azithromycin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Atovaquone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Azelaic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Azelastine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bortezomib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bosentan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cabergoline: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Calcipotriol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Calcitonin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Calcitriol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Bupropion: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Buprenorphine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Brimonidine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Brinzolamide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Budesonide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Atorvastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Armodafinil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Adalimumab: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Adapalene: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Adefovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Alendronic Acid & Colecalciferol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Acitretin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Acarbose: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Generic Benchmarking: Brand Erosion at Patent Expiry Healthcare |
March 2009 | £4000 |
|
Abacavir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Acarbose Pipeline Developer |
Ongoing | £2925 |
|
Alendronic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Alfuzosin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Amorolfine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Amphotericin B: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Anastrozole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Aripiprazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Amlodipine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Alverine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Aliskiren: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Almotriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Alprazolam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Candesartan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Capecitabine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Donepezil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Doramectin (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Doripenem: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Dorzolamide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Docetaxel: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Detomidine (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Deracoxib (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Desloratadine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Desvenlafaxine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Doxercalciferol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Doxorubicin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Eletriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Enalapril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Enfuvirtide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Enoxaparin sodium: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Efavirenz: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Edaravone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Drospirenone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Duloxetine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Dutasteride: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Dasatinib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Darbepoetin alfa: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ceftiofur (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cefuroxime: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Celecoxib: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cetuximab: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cefprozil: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cefditoren: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Carprofen (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Carvedilol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Caspofungin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ciclosporin (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ciclosporin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Clobetasol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Clonazepam: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Clopidogrel: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Clarithromycin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cladribine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ciprofloxacin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Cisatracurium: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Citalopram: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Olopatadine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ivermectin & Praziquantel (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Epoetin alfa: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Eprosartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Eptifibatide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Erlotinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Eplerenone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Entecavir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Enoxaparin sodium: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Enrofloxacin (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Entacapone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ertapenem: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Everolimus: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Filgrastim: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Finasteride: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Omega-3-acid ethyl esters: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Florfenicol (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fexofenadine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fesoterodine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Exemestane: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ezetimibe: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Famciclovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Enfuvirtide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Enalapril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Desvenlafaxine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Detomidine (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Docetaxel: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Donepezil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Desloratadine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Deracoxib (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Clopidogrel: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Darbepoetin alfa: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Dasatinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Doramectin (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Doripenem: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Dutasteride: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Edaravone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Efavirenz: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Eletriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Duloxetine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Drospirenone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Dorzolamide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Doxercalciferol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Doxorubicin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fluconazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fludarabine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Raloxifene: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ramelteon: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ramipril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rasagiline: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Itraconazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Isotretinoin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Irbesartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Irinotecan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Iron Sucrose: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Reboxetine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Repaglinide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rituximab: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rivastigmine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rizatriptan: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rocuronium Bromide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Ritonavir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Risperidone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Riluzole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rimonabant: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Risedronic Acid: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Indapamide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Imiquimod: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Frovatriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Gabapentin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Gadopentetic acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Galantamine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fosinopril: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Formoterol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fluticasone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fluvastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fluvoxamine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Gefitinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Gemcitabine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Hydroxychloroquine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ibandronic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Imatinib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Imidacloprid (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Hyaluronic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Hirudin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Glatiramer acetate: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Glimepiride: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Hepatitis B Vaccine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Clonazepam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Fipronil (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Abacavir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Acarbose: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Acitretin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Adalimumab: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ractopamine (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Rabeprazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pyriproxyfen (Vet): Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Quetiapine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Quinapril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Adapalene: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Adefovir: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Alprazolam: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Alverine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Amlodipine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Amorolfine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Almotriptan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Aliskiren: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Alendronic Acid & Colecalciferol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Alendronic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Alfuzosin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Pregabalin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pravastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Palonosetron: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pantoprazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Paricalcitol: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Paroxetine: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Paclitaxel: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Oxaliplatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Omeprazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Clobetasol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Orlistat: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pegfilgrastim: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pemetrexed: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Posaconazole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pramipexole: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Prasugrel: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pitavastatin: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pioglitazone: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Penciclovir: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Pergolide: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Perindopril: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Amphotericin B: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ondansetron: Core Country Coverage Pipeline Selector |
Ongoing | £260 |
|
Carvedilol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Caspofungin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cefprozil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ceftiofur (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Carprofen (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Capecitabine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Calcitonin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Calcitriol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Candesartan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cefuroxime: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Celecoxib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Citalopram: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cladribine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Clarithromycin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Anastrozole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cisatracurium: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ciprofloxacin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cetuximab: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ciclosporin (Vet): Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Ciclosporin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Calcipotriol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cefditoren: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Azelastine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Azithromycin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bevacizumab: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bicalutamide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Azelaic Acid: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Atovaquone: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Armodafinil: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Cabergoline: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Atorvastatin: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bimatoprost: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Barnidipine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Brinzolamide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bisoprolol: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Buprenorphine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bupropion: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Brimonidine: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Budesonide: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bosentan: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Bortezomib: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
Aripiprazole: Extended Country Coverage Pipeline Selector |
Ongoing | £610 |
|
European Generic Drug Market Potential The Emergence of Generic Drug Biologics |
February 2009 | £380 |
|
World Generic Market Report 2009 |
January 2009 | £595 |
|
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics 2009-2023 |
January 2009 | £1499 |
|
Company Profiles Medical Imaging Equipment Vendors |
December 2008 | £3820 |
|
World Generics Market, 2008-2013 |
November 2008 | £1499 |
|
Nipro Medical Device Company Intelligence Report |
November 2008 | £395 |
|
ConvaTec Medical Device Company Intelligence Report |
October 2008 | £395 |
|
Authorized Generics |
October 2008 | £215 |
|
Partnering in the Global Generics Industry 2008: A guide to companies |
July 2008 | £595 |
|
Injectable Generic Drugs Prospects & Opportunities to 2013 |
July 2008 | £1295 |
|
Top 10 Generic Pharmaceutical Companies, The Positioning, Performance and SWOT Analyses |
July 2008 | £1995 |
|
Generics Threats and Opportunities Mounting an Effective Defense Strategy |
June 2008 | £495 |
|
Commercial and Pipeline Insight: Opioids Short Acting and Anti-Abuse Technologies Set to Fragment and Grow The Market |
March 2008 | £7600 |
|
Generic League Market Analysis and Forecasts, 2007-2012, 2017 & 2022 |
February 2008 | £1999 |
|
Stockley's Drug Interactions Pocket Companion |
January 2008 | £22.95 |
|
Drug Testing: Technologies and Global Markets |
January 2008 | £3085 |
|
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry |
January 2008 | £650 |
|
Independence Technology Medical Device Company Intelligence Report |
December 2007 | £295 |
|
Cardiovascular Generic Drugs Prospects and Opportunities to 2012 |
December 2007 | £995 |
|
Generics Series Key Trends And Events In The 7 Major Markets |
December 2007 | £2005 |
|
Emerging Generic Drug Markets in Europe |
December 2007 | £795 |
|
Combating Generics Counter-Generics Strategy, Tactics and Execution |
December 2007 | £2095 |
|
Consolidation in the Generic Pharmaceutical Industry An evolving landscape |
October 2007 | £1250 |
|
Pharmaceutical Packaging Handbook |
September 2007 | £130 |
|
Protein Formulation and Delivery, 2nd edition |
September 2007 | £115 |
|
Generics in Europe |
August 2007 | £125 |
|
Generics in France |
August 2007 | £125 |
|
Generics in Germany |
August 2007 | £125 |
|
Generics in Canada |
August 2007 | £125 |
|
Generics in Asia-Pacific |
August 2007 | £125 |
|
Generics in Belgium |
August 2007 | £125 |
|
Generics in Japan |
August 2007 | £125 |
|
Generics in China |
August 2007 | £125 |
|
Generics in Italy |
August 2007 | £125 |
|
Generics in Spain |
August 2007 | £125 |
|
Generics in the United States |
August 2007 | £125 |
|
Global Generics |
August 2007 | £125 |
|
Generics in the Netherlands |
August 2007 | £125 |
|
Generics in the United Kingdom |
August 2007 | £125 |
|
Generic Drug Product Development: International Regulatory Requirements |
August 2007 | £115 |
|
Opportunities and Challenges for Generic Drugs in the UK 2007 |
June 2007 | £795 |
|
Generic Series: An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market |
June 2007 | £2005 |
|
Generic Drug Product Development: Specialty Drug Products |
June 2007 | £115 |
|
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs |
June 2007 | £115 |
|
Generic Drug Product Development Bioequivalence |
June 2007 | £115 |
|
Drug Metabolism: Chemical and Enzymatic Aspects |
June 2007 | £105 |
|
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs |
May 2007 | £995 |
|
Indian Bulk Drug Industry Insight 2007 |
May 2007 | £400 |
|
Smith & Nephew Medical Device Company Intelligence Report |
April 2007 | £395 |
|
2007 U.S. Drugs and Health and Beauty Aids Product Lines |
April 2007 | £125 |
|
World Pharmaceutical Markets Fact Book 2006; The |
March 2007 | £495 |
|
Generic Competition, 2007–11 The impact of patent expiries on sales of major drugs |
February 2007 | £1375 |
|
Emerging Generic Drug Companies Worldwide 2007 |
February 2007 | £595 |
|
Andrx Generics Company Intelligence Report |
January 2007 | £195 |
|
New Dynamics and Challenges in The Generics Market 2007 |
January 2007 | £1870 |
|
Sumitomo Pharmaceutical Company Intelligence Report |
December 2006 | £795 |
|
Generics: Global Industry Guide |
December 2006 | £575 |
|
Handbook of Drug Administration via Enteral Feeding Tubes 1st Edition |
November 2006 | £39.95 |
|
World Generic Market Report 2007 |
November 2006 | £595 |
|
Future Growth Opportunities in Generics The impact of consolidation on market and competitive dynamics |
November 2006 | £1495 |
|
Japan Generics Market Intelligence Report |
October 2006 | £295 |
|
Akzo Nobel Prospects to 2010 |
October 2006 | £795 |
|
Generics will play an increasingly important role in the pharma industry |
October 2006 | £895 |
|
When Patients Becomes Plaintiffs A Primer on Drug and Medical Device Liability |
October 2006 | £1095 |
|
Global Generics Industry Report |
September 2006 | £550 |
|
Altana Pharmaceutical Company Intelligence Report |
August 2006 | £795 |
|
Getinge Medical Device Company Intelligence Report |
August 2006 | £395 |
|
Germany Generics Market Intelligence Report |
August 2006 | £295 |
|
Asia Generic Pharmaceuticals Forecast Report; The |
July 2006 | £510 |
|
Global Generics Guide: Part 2 Benchmarking country markets and strategic issue |
June 2006 | £8695 |
|
Switzerland Generics Market Intelligence Report |
May 2006 | £295 |
|
World Generics Market 2006-2011; The |
May 2006 | £1499 |
|
Russia Generics Market Intelligence Report |
April 2006 | £295 |
|
Global Generics Guide Benchmarking the key players |
April 2006 | £4000 |
|
World Market for Prescription Generic Drugs; The 5th Edition |
April 2006 | £2230 |
|
Italy Generics Market Intelligence Report |
March 2006 | £295 |
|
Denmark Generics Market Intelligence Report |
March 2006 | £295 |
|
France Generics Market Intelligence Report 9 |
February 2006 | £295 |
|
Czech Republic Generics Market Intelligence Report |
January 2006 | £295 |
|
Global BioGenerics Market in 2010, The A Consensus Market Models report |
November 2005 | £195 |
|
Clarke's Analysis of Drugs & Poisons 2004 CD-ROM |
January 2004 | £411.25 |
|
Medicinal Use of Cannabis and Cannabinoids 1st Edition |
January 2004 | £39.95 |
